| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/12/2011 | US20110112169 RNAi-BASED THERAPEUTICS FOR ALLERGIC RHINITIS AND ASTHMA |
| 05/12/2011 | US20110112168 Novel sirna structures |
| 05/12/2011 | US20110112167 Therapeutic agents and targets |
| 05/12/2011 | US20110112166 Therapeutic cyclopentane derivatives |
| 05/12/2011 | US20110112165 Atorvastatin-aliskiren |
| 05/12/2011 | US20110112164 Novel polymorphs and processes for their preparation |
| 05/12/2011 | US20110112163 Cbi derivatives subject to reductive activation |
| 05/12/2011 | US20110112162 Spiro-oxindole compounds and their use as therapeutic agents |
| 05/12/2011 | US20110112161 Indole and indazole analogs as glycogen synthase activators |
| 05/12/2011 | US20110112160 Tablet comprising eprosartan mesylate |
| 05/12/2011 | US20110112159 Serotonin transporter gene and treament of alcoholism |
| 05/12/2011 | US20110112158 Benzisoxazole analogs as glycogen synthase activators |
| 05/12/2011 | US20110112157 Process for the preparation of zolmitriptan, salts and solvates thereof |
| 05/12/2011 | US20110112156 Bicyclic Derivatives as Modulators of Voltage Gated ION Channels |
| 05/12/2011 | US20110112155 Methods for treating cancer in patients having breast cancer resistance protein overexpression |
| 05/12/2011 | US20110112154 Compounds, compositions and methods |
| 05/12/2011 | US20110112153 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis |
| 05/12/2011 | US20110112152 Pyridone sulfonamides and pyridone sulfamides as mek inhibitors |
| 05/12/2011 | US20110112151 Compound capable of inhibiting 11-beta hydroxysteriod dehydrogenase |
| 05/12/2011 | US20110112150 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis |
| 05/12/2011 | US20110112149 Epothilone analogues, their pharmaceutical compositions, their use and their prepa rations |
| 05/12/2011 | US20110112148 Indoline compounds |
| 05/12/2011 | US20110112147 Indazolone analogs as glycogen synthase activators |
| 05/12/2011 | US20110112146 Chromene modulators of chemokine receptor activity |
| 05/12/2011 | US20110112145 Salts Of Methyl 2-((R))-(3-Chlorophenyl)((R)-1-((S)-2-(Methylamino)-3((R)-tetrahydro-2H-Pyran-3-YL)Propylcarbamoyl)Piperidin-3-YL)Methoxy)Ethylcarbamate |
| 05/12/2011 | US20110112144 Methods of preparing substituted heterocycles |
| 05/12/2011 | US20110112143 Allosteric modulators of metabotropic glutamate receptors |
| 05/12/2011 | US20110112142 Novel estrogen receptor ligands |
| 05/12/2011 | US20110112141 Crystals of laquinimod sodium, and process for the manufacture thereof |
| 05/12/2011 | US20110112140 Inhibitor of plasminogen activator inhibitor-1 |
| 05/12/2011 | US20110112139 Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/12/2011 | US20110112138 Multi-cyclic cinnamide derivatives |
| 05/12/2011 | US20110112137 Hiv protease inhibitor and cytochrome p450 inhibitor combinations |
| 05/12/2011 | US20110112136 Novel process for the manufacture of pharmaceutical preparations |
| 05/12/2011 | US20110112135 Imidazo [1,2-A] Pyridine Compounds |
| 05/12/2011 | US20110112134 Tricyclic Antagonists of Prostaglandin D2 Receptors |
| 05/12/2011 | US20110112133 Dihydro pyrroloquinoline derivatives |
| 05/12/2011 | US20110112132 Means for the treatment of acute and chronic disorders of cerebral circulation, including insult, based on hydrogenated pyrido (4,3-b) indoles (variants), pharmacological means based thereon and method for the use thereof |
| 05/12/2011 | US20110112131 Opioid-Ketamine and Norketamine Codrug Combinations for Pain Management |
| 05/12/2011 | US20110112130 Opioid-Nornicotine Codrugs Combinations for Pain Management |
| 05/12/2011 | US20110112129 Peripheral Phenolic Opioid Antagonist |
| 05/12/2011 | US20110112128 Method of treating ileus by pharmacological activation of cholinergic receptors |
| 05/12/2011 | US20110112127 Compounds and methods for kinase modulation, and indications therefor |
| 05/12/2011 | US20110112126 Enzyme inhibiting compounds |
| 05/12/2011 | US20110112123 Compositions for Intratumoral Administration |
| 05/12/2011 | US20110112122 EPIMINOCYCLOALKYL[b] INDOLE DERIVATIVES AS SEROTONIN SUB-TYPE 6 (5-HT6) MODULATORS AND USES THEREOF |
| 05/12/2011 | US20110112121 Pharmaceutical Compositions and Solid Forms |
| 05/12/2011 | US20110112120 Heteromonocyclic compound and use thereof |
| 05/12/2011 | US20110112119 Azabicyclooctyl-quinazolone derivatives useful as nicotinic acetylcholine receptor modulators |
| 05/12/2011 | US20110112118 2,4-Diaminoquinazolines for Spinal Muscular Atrophy |
| 05/12/2011 | US20110112117 Treatment of herpes virus related diseases |
| 05/12/2011 | US20110112116 Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditions |
| 05/12/2011 | US20110112115 Polymeric microemulsions |
| 05/12/2011 | US20110112114 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 05/12/2011 | US20110112113 Methods of predicting and treating adverse cardiac events |
| 05/12/2011 | US20110112112 Apogossypolone derivatives as anticancer agents |
| 05/12/2011 | US20110112111 Drug combinations comprising a dgat inhibitor and a ppar-agonist |
| 05/12/2011 | US20110112110 Antiproliferative compounds and therapeutic uses thereof |
| 05/12/2011 | US20110112109 Triazolone derivatives |
| 05/12/2011 | US20110112108 Pyridazine fungicides |
| 05/12/2011 | US20110112107 Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists |
| 05/12/2011 | US20110112106 Tricyclic inhibitors of 5-lipoxygenase |
| 05/12/2011 | US20110112105 Substituted heterocycle fused gamma-carbolines solid |
| 05/12/2011 | US20110112104 Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them. |
| 05/12/2011 | US20110112103 5-hydroxypyrimidine-4-carboxamide compound |
| 05/12/2011 | US20110112102 Method of treating cancer using a neuropeptide y 5r (np y5r) antagonist |
| 05/12/2011 | US20110112101 Treatment for ocular-related disorders |
| 05/12/2011 | US20110112100 Hepatitis C Virus Inhibitors |
| 05/12/2011 | US20110112099 Therapeutic agent for cancer resistant to protease inhibitor |
| 05/12/2011 | US20110112098 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules |
| 05/12/2011 | US20110112097 Substituted imidazoline-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof |
| 05/12/2011 | US20110112096 Pyrimidine derivatives as kinase inhibitors |
| 05/12/2011 | US20110112095 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof |
| 05/12/2011 | US20110112094 Methods of Treating Pulmonary Hypertension |
| 05/12/2011 | US20110112093 Pyrimidinyl-piperazines useful as d3/d2 receptor ligands |
| 05/12/2011 | US20110112092 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 05/12/2011 | US20110112091 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a methof of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |
| 05/12/2011 | US20110112090 Depsipeptides and Their Therapeutic Use |
| 05/12/2011 | US20110112089 Cysteine Protease Inhibitors |
| 05/12/2011 | US20110112088 Pyrazoles for the treatment of obesity and other cns disorders |
| 05/12/2011 | US20110112087 Thia-triaza-cyclopentazulenes |
| 05/12/2011 | US20110112086 Pyridinone analogs |
| 05/12/2011 | US20110112085 Thiazolopyrimidine pi3k inhibitor compounds and methods of use |
| 05/12/2011 | US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/12/2011 | US20110112083 Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof |
| 05/12/2011 | US20110112082 Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 05/12/2011 | US20110112081 Inhibitors of janus kinases |
| 05/12/2011 | US20110112080 Oxazoline derivatives |
| 05/12/2011 | US20110112079 Phosphodiesterase inhibitors |
| 05/12/2011 | US20110112078 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use |
| 05/12/2011 | US20110112077 Quinolizidinone m1 Receptor Positive Allosteric Modulators |
| 05/12/2011 | US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 05/12/2011 | US20110112075 Chlorothiophene-amides as inhibitors of coagulation factors xa and thrombin |
| 05/12/2011 | US20110112074 Chlorothiophene-isoxazoles as inhibitors of coagulation factors xa and thrombin |
| 05/12/2011 | US20110112073 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
| 05/12/2011 | US20110112072 Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof |
| 05/12/2011 | US20110112071 Novel heterocyclidene acetamide derivative |
| 05/12/2011 | US20110112070 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases |
| 05/12/2011 | US20110112069 Purin derivatives for use in the treatment of fab-related diseases |
| 05/12/2011 | US20110112068 Human immunodeficiency virus protease inhibitors |